CHF Solutions, Inc. To Announce Second Quarter 2020 Financial Results on August 4, 2020

Rhea-AI Summary

CHF Solutions, Inc. (NASDAQ: CHFS) will release its Q2 2020 financial results on August 4, 2020, at 9:00 AM ET. A conference call will follow, during which management will discuss performance and provide a business overview. The company specializes in medical devices aimed at treating fluid overload, with a focus on the Aquadex SmartFlow™ system. CHF Solutions has been publicly traded on Nasdaq since February 2012.

Positive

• Scheduled Q2 2020 financial results release may boost investor confidence.
• Focus on Aquadex SmartFlow™ system highlights commitment to innovative medical solutions.

Negative

• None.

EDEN PRAIRIE, Minn., July 28, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its second quarter 2020 financial results will be released on Tuesday, August 4, 2020. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.

To access the live webcast, please visit the Investors page of the CHF Solutions website at http://ir.chf-solutions.com or access the webcast directly at http://ir.chf-solutions.com/events.  Alternatively, you may access the live conference call by dialing (877) 303-9826 (U.S.) or (224) 357-2194 (international) and using conference ID: 3591247.  An audio archive of the webcast will be available following the call on the Investor page at http://ir.chf-solutions.com/events.

About CHF Solutions

CHF Solutions, Inc. (Nasdaq: CHFS) is a medical device company dedicated to improving the lives of patients suffering from fluid overload through science, collaboration, and innovation. The company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow™ system for ultrafiltration therapy. CHF Solutions is headquartered in Minneapolis, Minn., with wholly-owned subsidiaries in Australia and Ireland. The company has been listed on the Nasdaq Capital Market since February 2012.

CONTACTS:

INVESTORS:

Claudia Napal Drayton
Chief Financial Officer
CHF Solutions, Inc.
952-345-4205


- MEDIA:

Jessica Stewing
Health+Commerce
260-336-6202

FAQ

When will CHF Solutions release its Q2 2020 financial results?

CHF Solutions will release its Q2 2020 financial results on August 4, 2020.

What time is the conference call for CHF Solutions Q2 2020 results?

The conference call for CHF Solutions Q2 2020 results will take place at 9:00 AM ET on August 4, 2020.

How can I access CHF Solutions' financial results webcast?

You can access the webcast on the Investors page of CHF Solutions' website or directly at their events page.

What is the focus of CHF Solutions as a medical device company?

CHF Solutions is focused on developing, manufacturing, and commercializing the Aquadex SmartFlow™ system for ultrafiltration therapy.